Seasonal trading can be a benefit in stock selection. For an unknown reason, some equities perform well in some parts of the year and poorly in other parts of the year.

Since July 16, volatility in the markets has increased. Stocks have entered correction territory, with the Nasdaq 100 down 13% from its peak.

BLOOMFIELD, Conn. , Aug. 5, 2024 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced its first round of grant recipients for its new initiative to support youth mental health.

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.6%, we present two other groups of five DGI stocks each, with the goal of moderate to high yields.

Cigna's (CI) Q2 results reflect new client wins in the Evernorth Health Services unit, partly offset by elevated pharmacy costs. It continues to expect adjusted EPS of at least $28.40 for 2024.

The Cigna Group (NYSE:CI ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Ralph Giacobbe - SVP of IR David Cordani - Chairman and CEO Brian Evanko - CFO, and President and CEO, Cigna Healthcare Eric Palmer - President and CEO, Evernorth Health Services Conference Call Participants Justin Lake - Wolfe Research Lisa Gill - JPMorgan A.J. Rice - UBS Andrew Mok - Barclays Scott Fidel - Stephens Ryan Langston - TD Cowen Josh Raskin - Nephron Research George Hill - Deutsche Bank Erin Wright - Morgan Stanley Stephen Baxter - Wells Fargo Dave Windley - Jefferies Jessica Tassan - Piper Sandler Lance Wilkes - Bernstein Operator Ladies and gentlemen, thank you for standing by for the Cigna Group Second Quarter 2024 Results Review.

The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Cigna (CI) came out with quarterly earnings of $6.72 per share, beating the Zacks Consensus Estimate of $6.42 per share. This compares to earnings of $6.13 per share a year ago.

Cigna reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit.

Total revenues for the second quarter 2024 increased 25% to $60.5 billion Shareholders' net income for the second quarter 2024 was $1.5 billion, or $5.45 per share Adjusted income from operations1 for the second quarter 2024 was $1.9 billion, or $6.72 per share 2024 outlook2 for adjusted income from operations1,2 is at least $28.40 per share BLOOMFIELD, Conn. , Aug. 1, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong second quarter 2024 results reflecting broad-based revenue and earnings growth across its businesses.

The Cigna Group reported $1.5 billion in second quarter profits as the diversified provider of medical insurance, pharmacy benefits and health services reaped new clients.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.